Viking Therapeutics (VKTX) Tops Q3 EPS by 4c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Viking Therapeutic (VKTX) PT Raised to $87 at Truist Securities
• Citi expects Micron stock to rally into this event
• Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens